CytoSorb in patients with coronavirus disease 2019: A rapid evidence review and meta-analysis

BACKGROUND: After its approval by the European Union in 2011, CytoSorb therapy has been applied to control cytokine storm and lower the increased levels of cytokines and other inflammatory mediators in blood. However, the efficiency of this CytoSorb treatment in patients with coronavirus disease (CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Shilin, Zhang, Yanchun, Zhai, Kerong, Li, Jian, Li, Mingming, Yang, Jianbao, Zhang, Rongzhi, Li, Yongnan, Li, Zhenzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927009/
https://www.ncbi.nlm.nih.gov/pubmed/36798138
http://dx.doi.org/10.3389/fimmu.2023.1067214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927009/
https://www.ncbi.nlm.nih.gov/pubmed/36798138
http://dx.doi.org/10.3389/fimmu.2023.1067214

Ejemplares similares